New Study Shows Nuance Clinical Documentation Improvement Significantly Increases Case Mix Index during ICD-10 Transition
May 24 2016 - 08:30AM
Business Wire
Benchmark data shows Nuance helps hospitals and
health systems outperform in key financial, quality and
productivity metrics
Despite widespread industry concerns regarding the transition to
ICD-10, today Nuance Communications, Inc. (NASDAQ: NUAN) announced
that its clinical documentation improvement (CDI) clients have not
only sustained financial performance and quality through the
transition to ICD-10, but actually improved performance metrics
over ICD-9.
Highlights from the study include:
- An average 2.33% increase in CMI
post-ICD-10 across all Nuance CDI clients
- Up to 3% improvement in documentation
of comorbid conditions/major comorbid conditions (CC/MCC) that are
often missed in patient charts and important for quality of
care
- Average 88% review rate on Medicare
cases, exceeding the 80% benchmark considered success in the Nuance
CDI curriculum
- 93% physician response rate and an
agreement rate of 81%, exceeding benchmarks
- Exceeded the 15% impact clarification
benchmark, with four groups demonstrating an increase of 2.1%,
highlighting teams were keeping up on activities that drive
precision in documentation
This is a notable accomplishment since many provider
organizations expected revenue integrity challenges from the
initial coding transition and the incremental 5,500 codes from the
Centers for Medicare & Medicaid Services (CMS) coming in
October 2016. Hospital and health system leaders anticipate
increasing pressures on the clinical documentation process as new
codes continue to be introduced and their physicians face
ever-increasing demands on their time.
Benchmarking Data Shows Nuance’s Clinical CDI Approach
Delivers Superior OutcomesMore than 350 healthcare
organizations nationwide demonstrated that Nuance’s comprehensive
clinical approach to CDI resulted in a successful ICD-10 transition
with sustained positive impact in the first quarter following
October 1, 2015 when compared to April-September 2015 under
ICD-9.
Specifically, Nuance clients saw the following:
- Improved Case Mix Index – Case
Mix Index (CMI) directly impacts how providers are paid and gives
healthcare organizations valuable insights into all the Medicare
patients treated at the hospital. As a result of specialized ICD-10
education, advanced technology and direct physician-to-physician
engagement, providers using Nuance’s CDI program documented more
accurately and completely, leading to an average 2.33% increase in
CMI post-ICD-10 across all Nuance CDI clients.
- Better documentation of existing
clinical conditions – Nuance’s entire CDI client base saw an
average of up to 3% improvement in documentation of comorbid
conditions/major comorbid conditions (CC/MCC) that are often missed
in patient charts and are important for quality of care. This data
shows Nuance client sites are more accurately documenting
underlying conditions that reflect the severity of a patient’s
illness and underlying medical conditions, such as anemia, heart
failure, opioid dependence and protein calorie malnutrition, which
may warrant clinical interventions in some cases.
- Sustained productivity – Despite
the increased specificity and number of codes in ICD-10, chart
reviews, clinical clarifications by staff and physician response
rates continued without delays or bottlenecks following the ICD-10
transition, all without the need for additional CDI staff.
“Our benchmark data shows that despite the increased complexity
of, and fears about ICD-10, our CDI clients are actually improving
their performance on average. As healthcare provider organizations
struggle under the weight of increasing financial pressures and the
accelerating shift to value-based care, a best-in-class CDI
solution becomes vitally important to generate the appropriate
level of reimbursement, the highest quality scores and the correct
risk adjustment factor,” said Satish Maripuri, executive vice
president and general manager, Nuance Healthcare Division.
Using Nuance’s unique clinical CDI program, powered by the JATA
Compliant Documentation Management Program® and associated speech
recognition and clinical language understanding technologies,
physicians are able to document a more accurate and complete view
of a patient’s true clinical story. These drive better clinical and
financial outcomes while simultaneously helping physicians use
their EHR more efficiently. As part of Nuance’s technology-enhanced
CDI approach, clients are also leveraging next-generation,
computer-assisted physician documentation (CAPD) solutions to
provide real-time CDI clarifications directly within their normal
EHR-centric documentation workflows.
Nuance’s fully-managed, compliant CDI program has a leadership
history as the No. 1 CDI program in the industry as ranked by
hospital administrators, most recently reported by the 2015 Black
Book Clinical Documentation Improvement Solutions survey. The
program touches all aspects of an institution’s clinical
documentation process through technology and professional
services.
For more information on Nuance CDI, visit Nuance booth #609 at
The Association of Clinical Documentation Specialists conference
(ACDIS) in Atlanta May 24-26.
About Nuance Communications, Inc.Nuance Communications,
Inc. (NASDAQ: NUAN) is a leading provider of voice and language
solutions for businesses and consumers around the world. Its
technologies, applications and services make the user experience
more compelling by transforming the way people interact with
devices and systems. Every day, millions of users and thousands of
businesses experience Nuance’s proven applications. For more
information, please visit www.nuance.com. Connect with Nuance
on social media through the healthcare blog, What’s next, as
well as LinkedIn, and Twitter.
Nuance and the Nuance logo are trademarks or registered
trademarks of Nuance Communications, Inc. or its affiliates in the
United States and/or other countries. All other company names or
product names may be the trademarks of their respective owners.
The statements in this press release relating to future plans,
events or services, are forward-looking statements which are
subject to specific risks and uncertainties. There are a number of
factors which could cause actual events or results to differ
materially from those indicated in such forward looking statements,
including fluctuations in demand for the Nuance products, and the
continued development of Nuance products. The reader is warned not
to rely on these forward-looking statements without reservation,
since these are simply reflections of the current situation. Nuance
disclaims any obligation to update any forward-looking statements
as a result of developments occurring after the date of this
document.
Trademark reference: JATA Compliant Documentation Management
Program, Nuance Clintegrity CDI, and Advanced Practice CDI program
are registered trademarks or trademarks of Nuance Communications,
Inc. or its affiliates in the United States and/or other countries.
All other company names or product names referenced herein may be
the property of their respective owners.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160524005433/en/
Nuance Communications, Inc.Ann Joyal, 781-565-4155Media
Relationsann.joyal@nuance.com
Nuance Communications (NASDAQ:NUAN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nuance Communications (NASDAQ:NUAN)
Historical Stock Chart
From Mar 2023 to Mar 2024